Multicenter, Open-label, Phase IIIb Study to Evaluate the Safety, Tolerability of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Methotrexate or Other Non-biologic Disease-modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms TOZURA
- Sponsors Roche
- 17 Jun 2017 Results of pooled analysis presented at the 18th Annual Congress of the European League Against Rheumatism.
- 10 Jun 2017 Biomarkers information updated
- 04 Nov 2016 Status changed from active, no longer recruiting to completed.